IPO registrations (S-1, F-1) · Registrants
Manuka, Inc.
- SEC CIK
- 1062128 · filings on EDGAR ↗
- Name on the registration
- Artemis Therapeutics, Inc.
- Former names
- Artemis Therapeutics, Inc. (2016–2023); NEW YORK GLOBAL INNOVATIONS INC. (2013–2016); INKSURE TECHNOLOGIES INC. (2005–2014); INKSURE TECHNOLOGIES INC (2003–2005); LIL MARC INC (1998–2002)
- Registration
- Form S-1, first filed 2022-09-21, last 2023-01-04; 1 initial registration, 3 amendments
- Outcome
- Declared effective 2023-01-04
- Industry (SIC)
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics 2840
- Incorporated in
- DE
- Business address
- 3 ELIEZER VARDINON ST., Petach Tikva, L3 4959507
- EIN
- 84-1417774
- EDGAR entity type
- operating
- Insiders and CEO pay
- Manuka, Inc. on the corporate pages
Offering terms
- Shares offered
- 15,232,243 (all by selling holders)
- Listing
- OTC under the symbol ATMS
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: NEW YORK GLOBAL INNOVATIONS INC. EXACT (CIK (EXACT))
- SEC filer: Artemis Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-09-21 | S-1 | S-1 (registration) | Artemis Therapeutics, Inc. | 0001178913-22-003487 ↗ |
| 2022-11-21 | S-1/A | S-1/A (amendment) | Artemis Therapeutics, Inc. | 0001178913-22-004114 ↗ |
| 2022-12-20 | S-1/A | S-1/A (amendment) | Artemis Therapeutics, Inc. | 0001178913-22-004383 ↗ |
| 2023-01-04 | S-1/A | S-1/A (amendment) | Artemis Therapeutics, Inc. | 0001178913-23-000043 ↗ |
| 2023-01-04 | EFFECT | EFFECT (declared effective) | Artemis Therapeutics, Inc. | 9999999995-23-000030 ↗ |
| 2023-05-26 | EFFECT | EFFECT (declared effective) | Manuka, Inc. | 9999999995-23-001546 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-04 | S-1/A | registration statement | $1.30 | 15,232,243 | $19,801,915 | OTC ATMS | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SASS DAVID W | Director; Director,Officer | Secretary | 8 | 2006–2011 | |
| ACKS MICHAEL | Director | 2 | 2006 | ||
| ATTIAS ALBERT | Director | 4 | 2006–2008 | ||
| BIGON EYAL | Officer | Chief Financial Officer | 2 | 2006 | |
| GETTER PHILIP | Director | 5 | 2006–2008 | ||
| HOUSMAN ELIE | Director; Director,Officer | CEO & Chairman; Chairman and CEO; Chief Executive Officer | 7 | 2006–2008 | |
| LINEBERGER JAMES E | Director | 6 | 2006 | ||
| MEERFELD YARON | Director; Director,Officer | Acting Chief Executive Officer; Chief Operating Officer | 7 | 2006–2010 | |
| L & Co., LLC | Other; TenPercentOwner | 5 | 2006 | ||
| Schoenheimer Pierre Lucien | Director | 11 | 2006–2011 | ||
| BRANDT MICKEY | Officer | VP and CFO | 1 | 2006 | |
| Rock Randy F | Director | 7 | 2007–2010 | ||
| ICTS INTERNATIONAL N V | TenPercentOwner | 1 | 2007 | ||
| SEIDMAN SAMUEL N | Director | 4 | 2007–2008 | ||
| PEKER TZLIL | Officer | Chief Financial Officer; Vice President and CFO; VP & CFO | 4 | 2008–2010 | |
| Peleg Gadi | Director; Director,Officer | Chairman of the Board; Chairman ot the Board | 6 | 2008–2018 | |
| Raich Alon | Director | 5 | 2009–2011 | ||
| Gilat Tal | Officer | President and CEO | 2 | 2010–2012 | |
| Bettsak Jonathan | Director | 2 | 2010–2011 | ||
| Avner David | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 2 | 2010 | |
| Goldovsky Viktor | Officer | VP Sales and Buisness Dev | 2 | 2012 | |
| Assis Tomer | Officer | Chief Financial Officer | 1 | 2013 | |
| Arias Roberto Alonso Jimenez | Director | 1 | 2014 | ||
| Morris Chanan | Officer | Chief Financial Officer | 2 | 2014–2018 | |
| Alfassi Israel | Director | 1 | 2016 | ||
| Tonak Ltd. | TenPercentOwner | 2 | 2016–2017 | ||
| Wolf Dana | Officer | Chief Scientific Officer | 2 | 2016–2017 | |
| PAYNE PETER N. | Officer | Chief Executive Officer | 1 | 2017 | |
| Culley Brian M | Officer | Chief Executive Officer | 4 | 2017–2018 | |
| CITRON SHIMON | Director,Officer | Chief Executive Officer | 1 | 2022 | |
| Dana David | Officer | Chief Financial Officer | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-09-07 | NEW YORK GLOBAL INNOVATIONS INC. | Biotechnology | $500,000 | $500,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | NEW YORK GLOBAL INNOVATIONS INC. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | Artemis Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics, L3 first:
- Cloudtech Sensors, Inc PA
- Swisher Hygiene Inc. NC
- BIOLOGIX HAIR INC. FL
- ORIGIN TEA INC.
- Meiwu Technology Co Ltd
- Longevity Health Holdings, Inc. PA
- Orion Bliss Corp.
- Blue-Touch Holdings Group Co., Ltd F4
- Bowen Acquisition Corp NY
- Park Ha Biological Technology Co., Ltd. F4
In other datasets, the same topic (Health) in L3:
- Form D issuer: Agada Medical Ltd. (Form D private offerings)
Interests: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Health